{
    "relation": [
        [
            "",
            "13vPnC",
            "7vPnC"
        ],
        [
            "Description",
            "Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5mL dose of 13vPnC coadministered with ActHIB at 12-15 months of age (toddler dose).",
            "Participants received one single 0.5mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with ActHIB and Pediarix at 2, 4, 6 months (infant series). Participants received one single 0.5mL dose of 7vPnC coadministered with ActHIB at 12-15 months of age (toddler dose)."
        ]
    ],
    "pageTitle": "Study Evaluating Pneumococcal Vaccine in Healthy Infants - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00205803?sect=Xj0156&view=results",
    "hasHeader": true,
    "headerPosition": "MIXED",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042987228.91/warc/CC-MAIN-20150728002307-00186-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 856424579,
    "recordOffset": 856411948,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Reporting Groups Participants were enrolled into the study according to the inclusion/exclusion criteria without a screening period. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details Participants were recruited in the United States from September 2004 to September 2005. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Biological: 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) Biological: 7-Valent Pneumococcal Conjugate Vaccine (7vPnC) Interventions: Healthy Subjects Pneumococcal Infections Conditions: Allocation:\u00a0Randomized; \u00a0 Endpoint\u00a0Classification:\u00a0Safety\u00a0Study; \u00a0 Intervention\u00a0Model:\u00a0Parallel\u00a0Assignment; \u00a0 Masking:\u00a0Double-Blind; \u00a0 Primary\u00a0Purpose:\u00a0Prevention Study Design: Interventional Study Type:",
    "textAfterTable": "Participant Flow for 3 periods Period 1: \u00a0 Infant Series \u00a0 \u00a0 13vPnC \u00a0 \u00a0 7vPnC \u00a0 STARTED \u00a0 \u00a0 122 \u00a0 \u00a0 127 \u00a0 Vaccinated Dose 1 \u00a0 \u00a0 121 \u00a0 \u00a0 126 \u00a0 Vaccinated Dose 2 \u00a0 \u00a0 115 \u00a0 \u00a0 122 \u00a0 Vaccinated Dose 3 \u00a0 \u00a0 110 \u00a0 \u00a0 118 \u00a0 COMPLETED \u00a0 \u00a0 104 \u00a0 \u00a0 116 \u00a0 NOT COMPLETED \u00a0 \u00a0 18 \u00a0 \u00a0 11 \u00a0 Lost to Follow-up \u00a0 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}